Science Explorer Back to mapMap
Discussion
Institution · Progenics Pharmaceuticals (United States)

Most cited papers from Progenics Pharmaceuticals (United States)

Progenics Pharmaceuticals (United States)

What are the most cited papers from Progenics Pharmaceuticals (United States)?

The most cited paper from Progenics Pharmaceuticals (United States) is "HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5" (Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al., 1996), with 3,221 citations. Next come "CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5" (1,049) and "AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor" (769).

Showing 50 of 60 papers. Every paper with more than 91 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al. · Nature 20 Jun 1996 3,221
2 CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 Alexandra Trkola, Tatjana Dragic, James A. Arthos et al. · Nature Nov 1996 1,049
3 AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor George A. Donzella, Dominique Schols, Steven Lin et al. · Nature Medicine 1998 769
4 A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield Robert Pejchal et al. · Science Open access 14 Oct 2011 713
5 Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia Tino Schenk, Weihsu Claire Chen, Stefanie Göllner et al. · Nature Medicine Open access 11 Mar 2012 671
6 Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness Jay Thomas, Sloan Beth Karver, Gail Austin Cooney et al. · New England Journal of Medicine Open access 28 May 2008 597
7 A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure James Μ. Binley, Rogier W. Sanders, Brian Clas et al. · Journal of Virology Open access 15 Jan 2000 542
8 An Orphan Receptor Tyrosine Kinase Family Whose Members Serve as Nonintegrin Collagen Receptors Ajay Shrivastava, Czeslaw H. Radziejewski, Ernest B. Campbell et al. · Molecular Cell Open access Dec 1997 538
9 Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 Rogier W. Sanders, Mika Vesanen, Norbert Schuelke et al. · Journal of Virology Open access Sep 2002 462
10 Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study Michael J. Morris, Steven P. Rowe, Michael A. Gorin et al. · Clinical Cancer Research Open access 23 Feb 2021 401
11 A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY) Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology Open access 26 Feb 2021 389
12 Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1 Penny L. Moore, Emma T. Crooks, Lauren L. Porter et al. · Journal of Virology Open access 10 Feb 2006 348
13 Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120 Maxime Moulard, Hugues Lortat‐Jacob, Isabelle Mondor et al. · Journal of Virology Open access 15 Feb 2000 299
14 Efficacy and Safety of High-Specific-Activity 131 I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma Daniel A. Pryma, Bennett B. Chin, Richard B. Noto et al. · Journal of Nuclear Medicine Open access 5 Oct 2018 297
15 L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus Jason P. Gardner, Robert J. Durso, Robert R. Arrigale et al. · Proceedings of the National Academy of Sciences Open access 3 Apr 2003 295
16 CD81 is an entry coreceptor for hepatitis C virus Emmanuel G. Cormier, Fay Tsamis, Francis Kajumo et al. · Proceedings of the National Academy of Sciences Open access 3 May 2004 286
17 Receptor-independent Activators of Heterotrimeric G-protein Signaling Pathways Aya Takesono, Mary J. Cismowski, Catalina Ribas et al. · Journal of Biological Chemistry Open access Nov 1999 280
18 Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides Shengle Zhang, Carlos Cordon‐Cardo, Helen S. Zhang et al. · International Journal of Cancer 26 Sep 1997 280
19 Expression and Characterization of CD4-IgG 2 , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates Graham P. Allaway, Karen L. Davis-Bruno, Gary A. Beaudry et al. · AIDS Research and Human Retroviruses May 1995 233
20 The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy Norbert Schülke, Olga A. Varlamova, Gerald P. Donovan et al. · Proceedings of the National Academy of Sciences Open access 28 Oct 2003 233
21 Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke Judy Huang, David B. Agus, Christopher J. Winfree et al. · Proceedings of the National Academy of Sciences Open access 25 Sep 2001 228
22 Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5 William Clinton Olson, Gwénaël E. E. Rabut, Kirsten A. Nagashima et al. · Journal of Virology Open access May 1999 227
23 Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140 Alexandra Trkola, Thomas Joseph Ketas, Kirsten A. Nagashima et al. · Journal of Virology Open access 15 Jan 2001 224
24 Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer Aleksandar Obradovic, Diana Graves, Michael Korrer et al. · Clinical Cancer Research Open access 9 Mar 2022 220
25 Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry Tatjana Dragic, Alexandra Trkola, Steven Lin et al. · Journal of Virology Open access 1998 216
26 L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus Emmanuel G. Cormier, Robert J. Durso, Fotini Tsamis et al. · Proceedings of the National Academy of Sciences Open access 15 Sep 2004 213
27 The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C Tonie Cilliers, Jabulani Nhlapo, Mia Coetzer et al. · Journal of Virology Open access 12 Mar 2003 201
28 Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 Emmanuel G. Cormier, Marjan Persuh, Daniah A. D. Thompson et al. · Proceedings of the National Academy of Sciences Open access 23 May 2000 188
29 Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Russell K. Portenoy, Jay Thomas, Michele L. Moehl Boatwright et al. · Journal of Pain and Symptom Management Open access 26 Apr 2008 181
30 Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures Audray K. Harris, Mario Juan Borgnia, Dan Shi et al. · Proceedings of the National Academy of Sciences Open access 27 Jun 2011 162
31 Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization Emilia Falkowska, Francis Kajumo, Edie Garcia et al. · Journal of Virology Open access 17 May 2007 161
32 Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5 Carol E. Parker, Leesa J. Deterding, Christine Hager‐Braun et al. · Journal of Virology Open access 15 Nov 2001 157
33 Single‐Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV‐Infected Adults Jeffrey M. Jacobson, Israel Lowy, Courtney Vail Fletcher et al. · The Journal of Infectious Diseases Jul 2000 155
34 Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins James Μ. Binley, Rogier W. Sanders, Aditi Master et al. · Journal of Virology Open access 15 Mar 2002 154
35 Activation of Heterotrimeric G-protein Signaling by a Ras-related Protein Mary J. Cismowski, Chienling Ma, Catalina Ribas et al. · Journal of Biological Chemistry Open access Aug 2000 153
36 Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein Norbert Schülke, Mika Vesanen, Rogier W. Sanders et al. · Journal of Virology Open access 28 Jul 2002 152
37 HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells Meimei Shan, Per Johan Klasse, Kaustuv Banerjee et al. · PLoS Pathogens Open access 29 Oct 2007 151
38 A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors Elena Gabriela Chiorean, Patricia Mucci LoRusso, Robert Matthew Strother et al. · Clinical Cancer Research 27 Feb 2015 148
39 Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid Christopher M. Reilly, Nilamadhab Mishra, Julie M. Miller et al. · The Journal of Immunology Open access Sep 2004 146
40 Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions James Μ. Binley, Charmagne S. Cayanan, Cheryl Wiley et al. · Journal of Virology Open access 28 Apr 2003 144
41 Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 Complexes Emmanuel G. Cormier, Diep N. H. Tran, Liyana Yukhayeva et al. · Journal of Virology Open access 15 Jun 2001 137
42 Potent Antitumor Activity of an Auristatin-Conjugated, Fully Human Monoclonal Antibody to Prostate-Specific Membrane Antigen Dangshe Ma, Christine E. Hopf, Andrew D. Malewicz et al. · Clinical Cancer Research 15 Apr 2006 134
43 A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120 Emma T. Crooks, Penny L. Moore, Michael Franti et al. · Virology Open access 20 Jun 2007 129
44 Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542 Jeffrey M. Jacobson, Robert Joseph Israel, Israel Lowy et al. · Antimicrobial Agents and Chemotherapy Open access 24 Jan 2004 122
45 Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1 Simon A. Beddows, Norbert Schülke, Marc W. Kirschner et al. · Journal of Virology Open access Jul 2005 119
46 Quality by Design I: Application of Failure Mode Effect Analysis (FMEA) and Plackett–Burman Design of Experiments in the Identification of “Main Factors” in the Formulation and Process Design Space for Roller-Compacted Ciprofloxacin Hydrochloride Immediate-Release Tablets Raafat M. Fahmy, Ravikanth Kona, Ramesh Dandu et al. · AAPS PharmSciTech Open access 19 Sep 2012 118
47 PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer Clemens Kratochwil, Frederik Lars Giesel, Karin Leotta et al. · Journal of Nuclear Medicine Open access 22 Jan 2015 117
48 Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men Antoneta Granic, Karen Suetterlin, Tea Shavlakadze et al. · Clinical Science Open access Nov 2023 113
49 The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action Margaret S. Lee, Lisa M. Johansen, Yanzhen Zhang et al. · Cancer Research Dec 2007 113
50 In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen Xinning Wang, Dangshe Ma, William Clinton Olson et al. · Molecular Cancer Therapeutics 13 Jul 2011 112

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.